The company’s revenue for the quarter stood at $47.19 billion. Earnings per share rose 22.22% over the past year to … It is understandable that investor optimism is growing ahead of the company’s current quarter results. Several other equities research analysts have also commented on HCAT. Allianz Asset Management GmbH owned […] Zacks Investment Research lowered Health Catalyst from a buy rating to a hold rating in a research report on […] Inovalon Holdings story: Health Catalyst Reports Q3 Loss,Tops Revenue Estimates Nasdaq and other headlines for Inovalon Holdings BidaskClub upgraded shares of Health Catalyst (NASDAQ:HCAT) from a hold rating to a buy rating in a research note issued to investors on Tuesday, BidAskClub reports. Health Catalyst, Inc., which has a market valuation of $1.65 Billion as of writing, is expected to release its quarterly earnings report on Nov 10, 2020. Health Catalyst’s revenue for the quarter was up 19.8% compared to the same quarter last year. The company had revenue of $47.20 million during the quarter, compared to analysts’ expectations of $44.59 million. The fund owned 209,978 shares of the company’s stock after selling 22,384 shares during the period. Health Catalyst Announces Agreement to Acquire Vitalware, a Revenue Workflow Optimization and Analytics SaaS Technology Solution Email Print Friendly Share August 11, 2020 … Health Catalyst Inc. has a market valuation of $1.55 billion and last released its earnings reports on 11/10/2020, for the quarterly period ended on Sep 2020. Allianz Asset Management GmbH lessened its holdings in Health Catalyst, Inc. (NASDAQ:HCAT) by 9.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. Health Catalyst, which belongs to the Zacks Medical Info Systems industry, posted revenues of $43.26 million for the quarter ended June 2020, surpassing the … Catalyst Market Growth and Revenue Overview 2020| Post COVID-19 Impact Analysis by Size, Share, Product (Value, Volume and Types), Forecast to 2027 December 9, 2020 [email protected] The report brings to the fore a complete study of the Catalyst Market by giving an engrossing understanding of the bents of consumers that are compelling the industry. The average estimate of … Do the … NOV 10, 2020 - SALT LAKE CITY (AP) _ Health Catalyst Inc. (HCAT) on Tuesday reported a loss of $27.3 million in its third quarter.On a per-share basis, the Salt Lake City-based company said it had a loss of 68 cents. Health Catalyst (HCAT) delivered earnings and revenue surprises of 37.50% and 3.24%, respectively, for the quarter ended June 2020. Losses, adjusted for stock option expense and amortization costs, came to 21 cents per share.The results exceeded Wall Street expectations. Shares of Health Catalyst (NASDAQ:HCAT) rose 2.39% in after-market trading after the company reported Q3 results. Health Catalyst had a negative return on equity of 25.57% and a negative net margin of 48.17%. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0.
Executive Summary Of Nestle Malaysia, How Long Do Doves Live, Actions Speak Louder Than Words In Relationships Quotes, Approaches Of Managerial Judgement, Such An Awesome God Maverick City Chords In G, Buko Salad Calories,